ARCHIVES

Duke Retraction May Alter IOM Investigation; Review Panel Membership Announced

This article is from The Cancer Letter archive.

Vol. 36 No. 40 | November 5, 2010

Download PDF Visit The Full Archive

Related Articles

Possible Association Between Agent Orange, AML, IOM Says.

April 27, 2001

Lame Duck NCI Director: Cancer Centers Should Run Cancer Clinical Trials System

June 25, 2010

Senate Calls Cancer Research a Priority, Cites Research Task Force Funding Goal

October 8, 1999

$20 Million In Construction Funds Approved

April 2, 1976

Also R01 payline likely to fall below 20th percentile in FY04.

September 26, 2003

Intramural Review System Described

September 10, 1982